698 related articles for article (PubMed ID: 16988553)
1. Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation.
Bay A; Oner AF; Kose D; Dogan M
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):569-73. PubMed ID: 16988553
[TBL] [Abstract][Full Text] [Related]
2. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
3. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
4. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
7. High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
Eskici ZM; Açıkgöz Ş; Pişkin N; Mungan G; Can M; Güven B; Köktürk F
Acta Biochim Pol; 2012; 59(4):561-6. PubMed ID: 23094260
[TBL] [Abstract][Full Text] [Related]
8. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
[TBL] [Abstract][Full Text] [Related]
9. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
[TBL] [Abstract][Full Text] [Related]
10. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
[TBL] [Abstract][Full Text] [Related]
11. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
12. Global fibrinolytic capacity in children on dialysis.
Agras PI; Baskin E; Cengiz N; Kirazli S; Saatci U; Ozbek N
Thromb Res; 2005; 115(3):185-9. PubMed ID: 15617740
[TBL] [Abstract][Full Text] [Related]
13. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
14. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.
Sivula M; Pettilä V; Niemi TT; Varpula M; Kuitunen AH
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):419-26. PubMed ID: 19581801
[TBL] [Abstract][Full Text] [Related]
15. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
16. Laboratory testing in disseminated intravascular coagulation.
Favaloro EJ
Semin Thromb Hemost; 2010 Jun; 36(4):458-67. PubMed ID: 20614398
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of coagulation and fibrinolysis parameters for diagnostics of disseminated intravascular blood coagulation (DIC).
Lezhen T; Kramarev S; Kolesnik L; Kudinov S
Mater Med Pol; 1992; 24(2):79-81. PubMed ID: 1307773
[TBL] [Abstract][Full Text] [Related]
18. Disseminated intravascular coagulation in pediatric patients: clinical and laboratory features and prognostic factors influencing the survival.
Oren H; Cingöz I; Duman M; Yilmaz S; Irken G
Pediatr Hematol Oncol; 2005 Dec; 22(8):679-88. PubMed ID: 16251173
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis in disseminated intravascular coagulation.
Hack CE
Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]